NAVIDEA BIOPHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0381 USD | +1.33% |
|
+8.86% | -30.98% |
Chart calendar Navidea Biopharmaceuticals, Inc.
c3a068f471dda380.L_r09fGaowZwL08nFlK04TppwYJjHhVqkP-BoLCZcLU.XIKNm7er4V4-eSpocTjGo3QksuUqT1wg4JDi-P7ACPJBqZWEycrnNCBCdw~616c0c299f57c7950a7771634ea67ff2
Upcoming events on Navidea Biopharmaceuticals, Inc.
Past events on Navidea Biopharmaceuticals, Inc.
| 16/11/2023 18:00 | Annual General Meeting |
| 13/11/2023 | Q3 2023 Earnings Release |
| 27/07/2023 18:00 | Extraordinary Shareholders Meeting |
| 07/06/2023 21:00 | Q1 2023 Earnings Release |
| 21/03/2023 21:00 | Q4 2022 Earnings Call |
| 21/03/2023 20:01 | Q4 2022 Earnings Release |
| 08/12/2022 18:00 | Annual General Meeting |
| 15/11/2022 22:00 | Q3 2022 Earnings Call |
| 14/11/2022 13:00 | Q3 2022 Earnings Release |
| 10/11/2022 14:00 | Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161 |
| 09/11/2022 | American College of Rheumatology Convergence Conference |
| 08/09/2022 21:00 | Interim 2022 Earnings Call |
| 15/08/2022 13:30 | Interim 2022 Earnings Release |
| 12/06/2022 02:00 | Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197 |
| 12/05/2022 22:00 | Q1 2022 Earnings Call |
| 12/05/2022 12:30 | Q1 2022 Earnings Release |
| 20/04/2022 22:00 | NAV3-32 Phase 2B Study Results Call |
| 14/04/2022 22:00 | Business Update Call |
| 23/03/2022 21:00 | FY 2021 Earnings Call |
| 23/03/2022 11:30 | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,17 | 0,66 0,77 -14.18% | 0,92 0,90 2.18% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -11,0 -11,0 0.09% | -10,7 -12,1 11.2% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.17% | -10,7 -12,1 11.02% |
|
Net income Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.16% | -11,4 -12,1 5.51% |
|
EPS USD | Released Forecast Spread | -1,80 | -0,76 -0,74 -3.4% | -0,48 -0,48 0% |
| Announcement Date | - | 11/03/20 | 24/03/21 |
Quarterly results
| Fiscal Period | December | 2021 Q3 |
|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,10 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
|
Net income Million USD | Released Forecast Spread | -2,44 -3,52 30.8% |
|
EPS USD | Released Forecast Spread | -0,08 -0,11 27.27% |
| Announcement Date | 10/11/21 |
More events
Past sector events for Navidea Biopharmaceuticals, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
- Stock Market
- Equities
- NAVB Stock
- Calendar Navidea Biopharmaceuticals, Inc.
